P Valuesp Values News Today : Breaking News, Live Updates & Top Stories | Vimarsana

On October 17, 2023, Ardelyx Inc announced the FDA approval of tenapanor (Xphozah) for reducing serum phosphorus in adults with chronic kidney disease on dialysis as add-on therapy.

United statesGlenn chertowMike raabAdvisory committeeArdelyx incDrug administrationRenal drugs advisory committeeStanford universityNew drug applicationComplete response letterP valuesp valuesSerum phosphorusAdult patientsArdelyx receives complete response letterTreat hyperphosphatemiaWeek study